Advisory Advocates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Advisory Advocates's JNJ Position: Q2 2026 in Review
Advisory Advocates reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, selling an estimated $17K and leaving 1,825 shares worth $464K. The position accounts for 0.4% of the portfolio, ranked #91.
Advisory Advocates first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $464K in Q1 2026. 4,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Advisory Advocates held 1,825 shares of Johnson & Johnson worth $464K as of Q2 2026.
- Advisory Advocates sold 73 Johnson & Johnson shares in Q2 2026, an estimated $17K.
- Johnson & Johnson made up 0.4% of Advisory Advocates's portfolio in Q2 2026, its #91 holding.
- Advisory Advocates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
- Advisory Advocates's Johnson & Johnson position peaked at $464K in Q1 2026.
- 4,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.